Chaperone directed heterobifunctional molecules circumvent KRASG12C inhibitor resistance is a research paper published in Cancer Letters (2025). On theSindex it has a DataRank of 0. It has been cited 1 time.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
US Department of Defense Peer Reviewed Cancer Research Program
Grant: HT9425-23-1-0713
US Department of Defense Peer Reviewed Cancer Research Program
Grant: HT9425-23-1-0497
US Department of Defense Peer Reviewed Cancer Research Program
Grant: HT9425-23-1-0486
US Department of Defense Peer Reviewed Cancer Research Program
Grant: W81XWH-22-1-0023
NIH
Grant: CA230778
NCI NIH HHS
Grant: R01 CA230778
U.S. Department of Defense
Domingo Martínez Foundation
Ministerio de Ciencia, Innovación y Universidades
Cancer Center, University of Illinois at Chicago
MeSH Terms
Keywords